Burkert Biotech GmbH, a branch within the Burkert
group, has assumed assets and activities of Robolux AB. With
this step Burkert succeeds in further expanding its comprehensive
range of products and systems and strengthens its position in
the pharmaceutical, biotechnology and water treatment sectors.
Bengt Sahlin, Managing Director of Robolux, says "it is great
to become a part of a large organisation that can exploit the
full potential of the Robolux design, i. e. to combine two shut-off
valves in one valve body. This will give us a chance to find
new applications and markets such as Food & Beverage and
also cover new countries".
Mike Rodd, who will be in charge of the implementation of the
Robovalve products, is excited about this step as well, stating
that "this acquisition gives us a unique patented mulitway valve
which we can integrate into our existing product portfolio to
give our customer efficient process and system solutions". For
further information please contact
mike.rodd@burkert.com.
返回新闻报道
